Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)
Clinical trial NCT03259087 · COMPLETED
Trial details
- NCT number
- NCT03259087
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2018-01-28
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.